Major advances have been made in the field of idiopathic inflammatory myopathies (IIM), or myositis, that are likely to facilitate development of new therapeutic strategies that have not yet been applied in this group of diseases. These advances include new classification criteria to better identify the patients with IIM, detection of several new myositis-specific autoantibodies that facilitates subgrouping of patients into more specific clinical phenotypes, development of outcome measures for disease activity, and new response criteria. We have learned from clinical studies that exercise is an important part of treatment and that pharmacologic treatment should be combined with exercise.

Division of Rheumatology Department of Medicine Karolinska Institutet D2 01 Karolinska University Hospital Solna S 171 76 Stockholm Sweden

Divison of Physical Therapy Department of NVS Karolinska Institutet Huddinge Stockholm Sweden

Function Area Occupational Therapy and Physical Therapy Karolinska University Hospital Solna Stockholm Sweden

Institute of Rheumatology Na Slupi 4 12850 Praha 2 Czech Republic

Citace poskytuje Crossref.org